SPONSOR
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Total Trials
8
Recruiting
8
Phases
Phase 1, Phase 2, Phase 1, Phase 2, Phase 3
Conditions studied: Advanced CancersAlveolar Soft Part SarcomaMyeloid MalignancyNon Small Cell Lung CancerVasodilatory ShockBreast CancerB-cell LymphomaThyroid Neoplasms
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. is a clinical research sponsor with 8 registered studies on ClinicalTrials.gov, of which 8 are actively recruiting participants. Research covers conditions including Advanced Cancers, Alveolar Soft Part Sarcoma, Myeloid Malignancy, Non Small Cell Lung Cancer.
The trial portfolio spans Phase 1, Phase 2, Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
How many clinical trials has Chia Tai Tianqing Pharmaceutical Group Co., Ltd. sponsored?
ClinicalMetric currently tracks 8 clinical trials sponsored by Chia Tai Tianqing Pharmaceutical Group Co., Ltd., of which 8 are actively recruiting participants. These trials cover conditions including Advanced Cancers, Alveolar Soft Part Sarcoma, Myeloid Malignancy. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Chia Tai Tianqing Pharmaceutical Group Co., Ltd. research focus on?
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. clinical trials span Advanced Cancers, Alveolar Soft Part Sarcoma, Myeloid Malignancy, Non Small Cell Lung Cancer, Vasodilatory Shock, and additional conditions. The research pipeline includes Phase 1, Phase 2, Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Chia Tai Tianqing Pharmaceutical Group Co., Ltd. clinical trial?
To participate in a Chia Tai Tianqing Pharmaceutical Group Co., Ltd. trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Chia Tai Tianqing Pharmaceutical Group Co., Ltd. trials with current recruitment status updated daily.
Clinical Trials by Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
NCT06413953 Phase 1
Recruiting
A Clinical Study of TQB3107 Tablets in Patients With Malignant Tumors
Advanced Cancers
NCT07548177 Phase 2
Recruiting
Clinical Trials of Benmelstobart Injection Combined With Anlotinib Hydrochloride Capsules in the Treatment of Advanced or Unresectable Alveolar Soft Part Sarcoma
Alveolar Soft Part Sarcoma
NCT07011186 Phase 1, Phase 2
Recruiting
A Clinical Trial of TQB3909 Tablets in Combination With Azacitidine for the Treatment of Myeloid Malignancies
Myeloid Malignancy
NCT05913089 Phase 2
Recruiting
A Clinical Study of TQB2450 Injection Combined With Chemotherapy or Anlotinib Hydrochloride Capsule in the Treatment of Non Small Cell Lung Cancer
Non Small Cell Lung Cancer
NCT06351150 Phase 3
Recruiting
Efficacy and Safety of Angiotensin II Injection Versus Placebo in Patients With Refractory Distributed Shock
Vasodilatory Shock
NCT07697443 Phase 1, Phase 2
Recruiting
Clinical Trial of TQB3126 for Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy in Breast Cancer Subjects
Breast Cancer
NCT06566586 Phase 2
Recruiting
A Clinical Study to Evaluate the Efficacy and Safety of TQB3702 Tablets Combined With Immunochemotherapy for the Treatment of B-cell Lymphoma
B-cell Lymphoma
NCT05994365
Recruiting
Study of Anlotinib Hydrochloride Capsules in the Treatment of Locally Advanced or Metastatic Radioiodine-Refractory Differentiated Thyroid Carcinoma
Thyroid Neoplasms
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology